Related Experiment Video

Updated: Jan 18, 2026

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

2.2K

Current available therapies and future directions in the treatment of malignant gliomas

Annick Desjardins1, David A Reardon, James J Vredenburgh

  • 1Preston Robert Tisch Brain Tumor Center; Department of Medicine, Duke University Medical Center, Durham, NC, USA. desja002@mc.duke.edu

Biologics : Targets & Therapy
|August 27, 2009
PubMed

Insights

Malignant glioma (MG) treatment is poor, but new neuro-oncology advances offer hope. Research focuses on molecular targets, locoregional therapies, and combination strategies for better outcomes.

Area of Science:

  • Neuro-oncology
  • Molecular Genetics
  • Cancer Therapeutics

Background:

  • Malignant gliomas (MG) have a poor patient prognosis.
  • Recent neuro-oncology advances enhance understanding of MG.
  • This necessitates the development of novel therapeutic strategies.

Purpose of the Study:

  • To review current and future therapies for malignant gliomas.
  • To highlight novel molecular and locoregional treatment approaches.
  • To discuss the investigation of combination treatment strategies.

Main Methods:

  • Review of recent scientific literature and clinical trials.
  • Identification of molecular genetic and signal transduction pathway targets.
  • Evaluation of novel locoregional treatment delivery strategies.

Main Results:

  • Multiple molecular targets are under investigation for MG treatment.
  • Novel locoregional therapies and delivery methods are being explored.
  • Combination approaches are being studied to improve efficacy.

Conclusions:

  • Advances in understanding malignant gliomas are driving therapeutic innovation.
  • Future treatments will likely involve targeted molecular therapies and improved locoregional delivery.
  • Combination strategies hold promise for improving outcomes in malignant glioma patients.
Keywords:
glioblastomagliomakinase inhibitortargeted therapy

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.4K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K